National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19 Clinical Trial Optional)
Department of Health and Human Services
Reissue of PAR-20-119. This FOA encourages applications to advance the discovery, preclinical development, and proof of concept (PoC) testing of new, rationally based candidate agents and neurostimulation approaches to treat mental disorders, substance use disorders (SUDs) or alcohol use disorder (AUD), and to develop novel ligands and circuit-engagement devices as tools to further characterize existing or to validate new drug/device targets. Partnerships between academia and industry are strongly encouraged. This FOA supports a research program of multiple projects directed toward a specific major objective, basic theme or program goal, requiring a broadly based, multidisciplinary and often
Funding
Award size
Not specified
Type
Cooperative Agreement
Dates
Deadline
Later
Posted
01/15/2025
Closes
2027-10-25
Eligibility
Eligibility
Native American tribal governments (Federally recognized)Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationPrivate institutions of higher educationOthers (see text field entitled "Additional Information on Eligibility" for clarification)Small businessesIndependent school districtsCounty governmentsSpecial district governmentsNonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher educationState governmentsPublic and State controlled institutions of higher educationCity or township governmentsPublic housing authorities/Indian housing authoritiesFor profit organizations other than small businessesNative American tribal organizations (other than Federally recognized tribal governments)
Program
Funding area
Health - HL
Opportunity #
PAR-25-353
Source
Status
Open
Market
Government
Level
Federal
Source
Grants.gov